[1]
C. Jimeno, S. Kho, G. K. de los Santos, N. Buena-Bobis, and M. Villa, “The Multicenter, Open-Label, Observational LEAD-Ph Study: Real-World Safety and Effectiveness of Liraglutide in Filipino Participants with Type 2 Diabetes”, J ASEAN Fed Endocr Soc, vol. 33, no. 2, p. 114, Sep. 2018.